Management Report & Annexes | Fundamental Information About the Group

1.2 Group Strategy

In line with our mission “Bayer: Science For A Better Life,” we aim to improve people’s quality of life. For this endeavor, we focus on our core competency of developing and successfully commercializing innovative products and solutions based on scientific knowledge.

Entire focus on Life Science businesses

Bayer in future will focus entirely on the Life Science businesses – HealthCare and CropScience – and intends to float MaterialScience on the stock market as a separate company by mid-2016 at the latest. This move is designed to give MaterialScience direct access to the capital market for the continued development of its business. MaterialScience will align its organizational and process structures and corporate culture with its own industrial environment and business model in order to become a leading polymers company.

Our objective: profitable growth

Our corporate strategy is aligned toward profitable growth that will increase corporate value in the long term. We place special importance on developing new products and solutions that create significant value for customers and patients, and on serving the Emerging Markets, particularly those of Asia and Latin America. In this way we are giving more and more customers access to our products and establishing a solid basis for further growth.

The foundation for our success: innovation

Bayer is steadily opening up new, attractive market segments in fast-growing and research-driven areas of the Life Sciences. Our success is based on the development of new molecules, technologies, processes and business models. In the long term we expect additional growth impetus to come from interdisciplinary and interspecies research as we build on successful first steps in these areas. We aim to drive growth in our established business areas through investment in research and development as well as through acquisitions and collaborations. We are investing heavily to deliver organic growth in all areas of activity. Bayer plans to invest a total of over €6 billion in research and development and in property, plant and equipment in 2015.

Our actions: sustainable

Sustainable business practices are essential to the Group’s future viability. We therefore endeavor to balance our economic objectives with social and ecological requirements in the development, manufacturing and marketing of our products. We aim to ensure broad social acceptance for our business through responsible practices in the areas of compliance (e.g. anti-corruption and responsible marketing), human resources policy, product stewardship, health, environmental protection, safety and sup­plier management and by taking into account the expectations of important stakeholders.

Our most crucial resource: the employees

Motivated employees are especially important for the successful development of our business. Bayer embraces a performance- and development-oriented corporate culture, coupled with a pronounced sense of social responsibility. We encourage human and cultural diversity within the company, placing special importance on pleasant work environments, flexible working conditions and excellent vocational and advanced training opportunities. We offer excellent career prospects and aim to continue attracting the most talented people to support our company’s successful and sustainable development.

Last updated: February 26, 2015  Copyright © Bayer AG